Laszlo Szekely

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Journal article: JOURNAL OF MEDICAL CASE REPORTS. 2023;17(1):529

The D ∼ Sense ex-vivo viability assay application in a patient with stage IV lung adenocarcinoma: a case report

Zhang Y; Wu X; He P; Wu J; Gu X; Bendek M; Otvos R; Szekely L
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2022;56(1):166-173

Morphological changes without histological myocarditis in hearts of COVID-19 deceased patients

Razaghi A; Szakos A; Al-Shakarji R; Bjornstedt M; Szekely L
Article: BMC BIOINFORMATICS. 2022;23(1):546

AtlasGrabber: a software facilitating the high throughput analysis of the human protein atlas online database

Bozoky B; Szekely L; Ernberg I; Savchenko A
Article: NATURE METABOLISM. 2022;4(12):1674-1683

COVID-19 instigates adipose browning and atrophy through VEGF in small mammals

Jing X; Wu J; Dong C; Gao J; Seki T; Kim C; Urgard E; Hosaka K; Yang Y; Long S; Huang P; Zheng J; Szekely L; Zhang Y; Tao W; Coquet J; Ge M; Chen Y; Adner M; Cao Y
Article: DIAGNOSTICS. 2022;12(11):2789

Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers

Razaghi A; Szakos A; Alouda M; Bozoky B; Bjornstedt M; Szekely L
Article: NEOPLASIA. 2021;23(12):1300-1306

Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epithelium

Bozoky B; Moro CF; Strell C; Geyer N; Heuchel RL; Lohr JM; Ernberg I; Szekely L; Gerling M; Bozoky B
Article: CELL REPORTS. 2021;37(4):109892

Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL^pro substrate degradome

Pablos I; Machado Y; de Jesus HCR; Mohamud Y; Kappelhoff R; Lindskog C; Vlok M; Bell PA; Butler GS; Grin PM; Cao QT; Nguyen JP; Solis N; Abbina S; Rut W; Vederas JC; Szekely L; Szakos A; Drag M; Kizhakkedathu JN; Mossman K; Hirota JA; Jan E; Luo H; Banerjee A; Overall CM
Article: MALARIA JOURNAL. 2021;20(1):303

Direct contact between Plasmodium falciparum and human B-cells in a novel co-culture increases parasite growth and affects B-cell growth

Reddy SB; Nagy N; Ronnberg C; Chiodi F; Lugaajju A; Heuts F; Szekely L; Wahlgren M; Persson KEM
Article: ISCIENCE. 2021;24(5):102420

Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2

Saccon E; Chen X; Mikaeloff F; Rodriguez JE; Szekely L; Vinhas BS; Krishnan S; Byrareddy SN; Frisan T; Vegvari A; Mirazimi A; Neogi U; Gupta S
Article: HELIYON. 2021;7(5):e07134

Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death

Szekely L; Bozoky B; Bendek M; Ostad M; Lavignasse P; Haag L; Wu J; Jing X; Gupta S; Saccon E; Sonnerberg A; Cao Y; Bjornstedt M; Szakos A
Article: ONCOGENESIS. 2018;7(11):84

Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia

Ge Z; Han Q; Gu Y; Ge Q; Ma J; Sloane J; Gao G; Payne KJ; Szekely L; Song C; Dovat S
Article: GASTROENTEROLOGY RESEARCH AND PRACTICE. 2018;2018:7345426-7

Diminished DEFA6 Expression in Paneth Cells Is Associated with Necrotizing Enterocolitis

Markasz L; Wanders A; Szekely L; Lilja HE
Article: SCIENTIFIC REPORTS. 2018;8(1):11014

Cellular-resolution 3D virtual histology of human coronary arteries using x-ray phase tomography

Vagberg W; Persson J; Szekely L; Hertz HM
Article: EXPERIMENTAL HEMATOLOGY. 2016;44(1):38-49.e1

Sensitivity of chronic lymphocytic leukemia cells to small targeted therapeutic molecules: An in vitro comparative study

Sylvan SE; Skribek H; Norin S; Muhari O; Osterborg A; Szekely L
Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2015;34(1):62

Confrontation of fibroblasts with cancer cells in vitro: gene network analysis of transcriptome changes and differential capacity to inhibit tumor growth

Alexeyenko A; Alkasalias T; Pavlova T; Szekely L; Kashuba V; Rundqvist H; Wiklund P; Egevad L; Csermely P; Korcsmaros T; Guven H; Klein G
Article: GENES AND CANCER. 2015;6(3-4):119-128

Drug sensitivity profiling and molecular characteristics of cells from pleural effusions of patients with lung adenocarcinoma.

Ötvös R; Szulkin A; Hillerdal C-O; Celep A; Yousef-Fadhel E; Skribek H; Hjerpe A; Székely L; Dobra K
Article: CELLULAR SIGNALLING. 2015;27(2):363-372

Inhibition of protein phosphatase-1 and -2A decreases the chemosensitivity of leukemic cells to chemotherapeutic drugs

Dedinszki D; Kiss A; Markasz L; Marton A; Toth E; Szekely L; Erdodi F
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2014;111(48):17188-17193

Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent

Alkasalias T; Flaberg E; Kashuba V; Alexeyenko A; Pavlova T; Savchenko A; Szekely L; Klein G; Guven H
Article: BMC CANCER. 2014;14:709

Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

Szulkin A; Otvos R; Hillerdal C-O; Celep A; Yousef-Fadhel E; Skribek H; Hjerpe A; Szekely L; Dobra K
Article: CANCER MEDICINE. 2014;3(3):485-491

Decreased decorin expression in the tumor microenvironment

Bozoky B; Savchenko A; Guven H; Ponten F; Klein G; Szekely L
Article: ANTICANCER RESEARCH. 2014;34(2):893-898

Molecular Typing of Human Herpesvirus 8 Isolates from Patients with Kaposi's Sarcoma in Hungary

Oetvoes R; Juhasz A; Szalai E; Ujvari D; Oetvoes K; Szabo K; Remenyik E; Szekely L; Gergely L; Konya J
Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(2):286-293

Novel signatures of cancer-associated fibroblasts

Bozoky B; Savchenko A; Csermely P; Korcsmaros T; Dul Z; Ponten F; Szekely L; Klein G
Article: PLOS ONE. 2013;8(7):e69781

Improved In Vitro Culture of Plasmodium falciparum Permits Establishment of Clinical Isolates with Preserved Multiplication, Invasion and Rosetting Phenotypes

Ribacke U; Moll K; Albrecht L; Ismail HA; Normark J; Flaberg E; Szekely L; Hultenby K; Persson KEM; Egwang TG; Wahlgren M
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(10):2274-2283

The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth

Flaberg E; Guven H; Savchenko A; Pavlova T; Kashuba V; Szekely L; Klein G
Article: APMIS. 2012;120(10):786-793

Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice

Schennings T; Farnebo F; Szekely L; Flock J-I
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(33):13231-13236

Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan

Cheng H-H; Kuo C-C; Yan J-L; Chen H-L; Lin W-C; Wang K-H; Tsai KK-C; Guven H; Flaberg E; Szekely L; Klein G; Wu KK
Article: BREAST CANCER RESEARCH. 2012;14(4):R114

High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer

Li J; Szekely L; Eriksson L; Heddson B; Sundbom A; Czene K; Hall P; Humphreys K
Journal article: PLOS ONE. 2012;7(7):10.1371/annotation/3ac2b8

Correction: Symbionts as Major Modulators of Insect Health: Lactic Acid Bacteria and Honeybees

VÃ¡squez A; Forsgren E; Fries I; Paxton RJ; Flaberg E; Szekely L; Olofsson TC
Article: FASEB JOURNAL. 2012;26(6):2374-2382

Rho GTPases link cellular contractile force to the density and distribution of nanoscale adhesions

Gad AKB; Ronnlund D; Spaar A; Savchenko AA; Petranyi G; Blom H; Szekely L; Widengren J; Aspenstrom P
Article: PLOS ONE. 2012;7(3):e33188

Symbionts as Major Modulators of Insect Health: Lactic Acid Bacteria and Honeybees

Vasquez A; Forsgren E; Fries I; Paxton RJ; Flaberg E; Szekely L; Olofsson TC
Article: BMC CANCER. 2011;11:441

Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines

Otvos R; Skribek H; Kis LL; Gloghini A; Markasz L; Flaberg E; Eksborg S; Konya J; Gergely L; Carbone A; Szekely L
Article: CELL CYCLE. 2011;10(19):3346-3358

Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2

Li H; Lakshmikanth T; Garofalo C; Enge M; Spinnler C; Anichini A; Szekely L; Karre K; Carbone E; Selivanova G
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(12):2793-2802

High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts

Flaberg E; Markasz L; Petranyi G; Stuber G; Dicso F; Alchihabi N; Olah E; Csizy I; Jozsa T; Andren O; Johansson J-E; Andersson S-O; Klein G; Szekely L
Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(4):817-825

Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53

Kashuba E; Yurchenko M; Yenamandra SP; Snopok B; Szekely L; Bercovich B; Ciechanover A; Klein G
Article: EXPERIMENTAL HEMATOLOGY. 2010;38(12):1219-1230

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin

Skribek H; Otvos R; Flaberg E; Nagy N; Markasz L; Eksborg S; Masszi T; Kozma A; Adam E; Miseta A; Klein E; Szekely L
Article: CANCER RESEARCH. 2010;70(8):3372-3381

Rescue of p53 Function by Small-Molecule RITA in Cervical Carcinoma by Blocking E6-Mediated Degradation

Zhao CY; Szekely L; Bao W; Selivanova G
Article: FREE RADICAL BIOLOGY AND MEDICINE. 2009;47(11):1661-1671

High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy

Eriksson SE; Prast-Nielsen S; Flaberg E; Szekely L; Arner ESJ
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(47):19866-19871

MRPS18-2 protein immortalizes primary rat embryonic fibroblasts and endows them with stem cell-like properties

Kashuba E; Yenamandra SP; Darekar SD; Yurchenko M; Kashuba V; Klein G; Szekely L
Article: BIOMEDICINE & PHARMACOTHERAPY. 2009;63(6):413-420

NK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab

Markasz L; Vanherberghen B; Flaberg E; Otvos R; Stuber G; Jernberg AG; Olah E; Skribek H; Szekely L
Article: MOLECULAR CANCER. 2009;8:23

PRIMA-1^MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein

Stuber G; Flaberg E; Petranyi G; Otvos R; Rokaeus N; Kashuba E; Wiman KG; Klein G; Szekely L
Article: EXPERIMENTAL ONCOLOGY. 2008;30(4):327-329

Immunofluorescence staining of paraffin sections: creating DAB staining like virtual digital images using CMYK color conversion.

Buchynska L; Kashuba E; Szekely L
Article: BMC MEDICAL IMAGING. 2008;8:13

Extended Field Laser Confocal Microscopy (EFLCM): combining automated Gigapixel image capture with in silico virtual microscopy.

Flaberg E; Sabelström P; Strandh C; Szekely L
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008;105(14):5489-5494

EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes

Kashuba E; Yurchenko M; Yenamandra SP; Snopok B; Isaguliants M; Szekely L; Klein G
Article: JOURNAL OF IMMUNOTHERAPY. 2008;31(3):283-293

Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes

Markasz L; Skribek H; Uhlin M; Otvos R; Flaberg E; Eksborg S; Olah E; Stuber G; Szekely L
Article: LEUKEMIA & LYMPHOMA. 2007;48(9):1835-1845

Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel

Markasz L; Kis LL; Stuber G; Flaberg E; Otvos R; Eksborg S; Skribek H; Olah E; Szekely L
Article: MOLECULAR CANCER. 2007;6:28

HHV-8 encoded LANA-I alters the higher organization of the cell nucleus

Stuber G; Mattsson K; Flaberg E; Kati E; Markasz L; Sheldon JA; Klein G; Schulz TF; Szekely L
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2007;104(10):3919-3924

Filamin B deficiency in mice results in skeletal malformations and impaired microvascular development

Zhou X; Tian F; Sandzen J; Cao R; Flaberg E; Szekely L; Cao Y; Ohlsson C; Bergo MO; Boren J; Akyurek LM
Article: ONCOGENE. 2007;26(7):982-992

PRIMA-1^MET induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins

Rokaeus N; Klein G; Wiman KG; Szekely L; Mattsson K
Article: MOLECULAR CANCER THERAPEUTICS. 2007;6(2):644-654

Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells

Markasz L; Stuber G; Vanherberghen B; Flaberg E; Olah E; Carbone E; Eksborg S; Klein E; Skribek H; Szekely L
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2006;386(7-8):2063-2073

SPR-based immunocapture approach to creating an interfacial sensing architecture: mapping of the MRS18-2 binding site on retinoblastoma protein

Snopok B; Yurchenko M; Szekely L; Klein G; Kashuba E
Article: BMC CANCER. 2006;6:265

Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells

Markasz L; Stuber G; Flaberg E; Jernberg AG; Eksborg S; Olah E; Skribek H; Szekely L
Article: ACTA HISTOCHEMICA ET CYTOCHEMICA. 2006;39(4):103-106

Multi-dimensional laser confocal microscopy on live cells in submicroliter volumes using glass capillaries

Flaberg E; Stuber G; Szekely L
Article: GENES CHROMOSOMES & CANCER. 2006;45(5):470-481

Molecular classification of mucoepidermoid carcinomas -: Prognostic significance of the MECT1-MAML2 fusion oncogene

Behboudi A; Enlund F; Winnes M; Andrén Y; Nordkvist A; Leivo I; Flaberg E; Szekely L; Mäkitie A; Grenman R; Mark J; Stenman G
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2006;281(2):1215-1223

Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein

Kashuba EV; Gradin K; Isaguliants M; Szekely L; Poellinger L; Klein G; Kazlauskas A
Article: EXPERIMENTAL CELL RESEARCH. 2005;303(1):47-55

Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein

Kashuba E; Yurchenko M; Szirak K; Stahl J; Klein G; Szekely L
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;107(4):597-602

Upregulation of the truncated basic hair keratin 1(hHb1-ΔN) in carcinoma cells by Epstein-Barr virus (EBV)

Nishikawa J; Kiss C; Imai S; Takada K; Okita K; Klein G; Szekely L
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;105(5):644-653

EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells

Kashuba E; Mattsson K; Pokrovskaja K; Kiss C; Protopopova M; Ehlin-Henriksson B; Klein G; Szekely L
Article: JOURNAL OF VIROLOGY. 2003;77(12):7093-7100

A domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus affects transcriptional activation and binding to nuclear heterochromatin

Viejo-Borbolla A; Kati E; Sheldon JA; Nathan K; Mattsson K; Szekely L; Schulz TF
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003;100(8):4813-4818

T cell leukemia 1 oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines

Kiss C; Nishikawa J; Takada K; Trivedi P; Klein G; Szekely L
Article: BMC MICROBIOLOGY. 2003;3:6

Ebola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cells -: art. no. 6

Björndal AS; Szekely L; Elgh F
Article: MOLECULAR CANCER. 2003;2:18

p14ARF induces the relocation of HDM2 and p53 to extranucleolar sites that are targeted by PML bodies and proteasomes.

Kashuba E; Mattsson K; Klein G; Szekely L
Article: JOURNAL OF VIROLOGICAL METHODS. 2003;107(2):195-203

Improved subtractive suppression hybridization combined with high density cDNA array screening identifies differentially expressed viral and cellular genes

Kiss C; Nishikawa J; Dieckmann A; Takada K; Klein G; Szekely L
Article: BMC CELL BIOLOGY. 2002;3:23

Epstein-Barr virus encoded nuclear protein EBNA-3 binds a novel human uridine kinase/uracil phosphoribosyltransferase

Kashuba E; Kashuba V; Sandalova T; Klein G; Szekely L
Article: INTERNATIONAL JOURNAL OF CANCER. 2002;99(5):705-712

CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines

Pokrovskaja K; Ehlin-Henriksson B; Kiss C; Challa A; Gordon J; Gogolak P; Klein G; Szekely L
Article: NEW BIOTECHNOLOGY. 2002;19(1):31-34

Optimisation of the degenerate oligonucleotide primed PCR (DOP-PCR) for capillary thermocycler

Kiss C; Kost-Alimova M; Klein G; Szekely L
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2002;277(19):17009-17015

Identification of ERp29, an endoplasmic reticulum lumenal protein, as a new member of the thyroglobulin folding complex

Sargsyan E; Baryshev M; Szekely L; Sharipo A; Mkrtchian S
Article: JOURNAL OF GENERAL VIROLOGY. 2002;83(Pt 1):179-188

Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions

Mattsson K; Kiss C; Platt GM; Simpson GR; Kashuba E; Klein G; Schulz TF; Szekely L
Article: VIROLOGY. 2001;288(2):275-282

Intranuclear localization of the transcription coadaptor CBP/p300 and the transcription factor RBP-Jk in relation to EBNA-2 and-5 in B lymphocytes

Bandobashi K; Maeda A; Teramoto N; Nagy N; Székely L; Taguchi H; Miyoshi I; Klein G; Klein E
Article: JOURNAL OF HUMAN VIROLOGY. 2001;4(5):227-237

Epstein-Barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins

Maeda A; Bandobashi K; Nagy N; Teramoto N; Gogolák P; Pokrovskaja K; Székely L; Björkholm M; Klein G; Klein E
Article: INTERNATIONAL JOURNAL OF CANCER. 2001;93(5):714-719

EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain

Maeda A; Kiss C; Chen F; Ehlin-Henriksson B; Nagy N; Szekely L; Takada K; Klein E; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 2001;82(Pt 2):345-358

Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5

Pokrovskaja K; Mattsson K; Kashuba E; Klein G; Szekely L
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2001;98(3):1012-1017

Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation

Mattsson K; Pokrovskaja K; Kiss C; Klein G; Szekely L
Article: BRITISH JOURNAL OF CANCER. 2001;84(1):122-125

A prospective seroepidemiological study of human herpesvirus-8 infection and the risk of multiple myeloma

Tedeschi R; Kvarnung M; Knekt P; Schulz TF; Szekely L; De Paoli P; Aromaa A; Teppo L; Dillner J
Article: INTERNATIONAL JOURNAL OF CANCER. 2000;88(3):439-447

SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines

Nagy N; Cerboni C; Mattsson K; Maeda A; Gogolák P; Sümegi J; Lányi A; Székely L; Carbone E; Klein G; Klein E
Article: ONCOGENE. 2000;19(14):1801-1806

Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen

Kashuba E; Kashuba V; Pokrovskaja K; Klein G; Szekely L
Article: JOURNAL OF GENERAL VIROLOGY. 1999;80:2889-2900

Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies

Szekely L; Kiss C; Mattsson K; Kashuba E; Pokrovskaja K; Juhasz A; Holmvall P; Klein G
Article: APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY. 1999;7(3):226-236

Computer programs that allow fast acquisition, visualization and overlap quantitation of fluorescent 3D microscopic objects by using nearest-neighbor deconvolution algorithm

Holmvall P; Szekely L
Journal article: APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY. 1999;7(3):226

Computer Programs That Allow Fast Acquisition, Visualization and Overlap Quantitation of Fluorescent 3D Microscopic Objects by Using Nearest-Neighbor Deconvolution Algorithm

Holmvall P; Szekely L
Article: INTERNATIONAL JOURNAL OF CANCER. 1999;81(4):543-550

Expression of cyclin D2 and D3 in lymphoid lesions

Teramoto N; Pokrovskaja K; Szekely L; Polack A; Yoshino T; Akagi T; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 1999;80:987-995

Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis

Pokrovskaja K; Okan I; Kashuba E; Löwbeer M; Klein G; Szekely L
Article: JOURNAL OF HUMAN VIROLOGY. 1999;2(1):33-37

Epstein-Barr virus-encoded nuclear protein EBNA-3 interacts with the ε-subunit of the T-complex protein 1 chaperonin complex

Kashuba E; Pokrovskaja K; Klein G; Szekely L
Article: JOURNAL OF HUMAN VIROLOGY. 1998;1(5):307-313

Differential expression and localization of EBER-1 and EBER-2 in Epstein-Barr virus-carrying cells.

Teramoto N; Szekely L; Klein G
Article: JOURNAL OF VIROLOGICAL METHODS. 1998;73(1):89-97

Simultaneous detection of two independent antigens by double staining with two mouse monoclonal antibodies

Teramoto N; Szekely L; Pokrovskaja K; Hu LF; Yoshino T; Akagi T; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 1998;79:1445-1452

Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line

Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
Article: JOURNAL OF VIROLOGY. 1998;72(4):2969-2974

Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP-1-coding upstream regulatory region and an origin of DNA replication (oriP)

Falk KI; Szekely L; Aleman A; Ernberg I
Article: MOLECULAR AND CELLULAR BIOLOGY. 1998;18(2):1084-1093

The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein

Alcalay M; Tomassoni L; Colombo E; Stoldt S; Grignani F; Fagioli M; Szekely L; Helin K; Pelicci PG
Article: TRENDS IN MICROBIOLOGY. 1997;5(11):424-425

Multiple myeloma and Kaposi's sarcoma-associated herpesvirus - a paracrine model of tumorigenesis?

Szekely L; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 1997;78:2031-2040

Epstein-Barr virus-encoded LMP1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins

Pokrovskaja K; Trivedi P; Klein G; Szekely L
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1997;45(6):678-682

Conversion of in vitro cultured human monocytes into effective presenters of an HER2/neu-encoded CTL peptide epitope

Wasserman K; Corsi MM; Szekely L; Kono K; Maes HH; Kiessling R
Article: EXPERIMENTAL CELL RESEARCH. 1997;233(1):25-32

Endogenous fibronectin of blood polymorphonuclear leukocytes: Immunochemical characterization and subcellular localization

Salcedo R; Segura C; Szekely L; deMesquita R; Biberfeld P; Patarroyo M
Article: MOLECULAR CANCER RESEARCH. 1997;8(5):599-609

Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines

Szekely L; Pokrovskaja K; Klein G
Article: MOLECULAR CANCER RESEARCH. 1996;7(12):1723-1732

Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines

Pokrovskaja K; EhlinHenriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Article: JOURNAL OF VIROLOGY. 1996;70(4):2562-2568

The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies

Szekely L; Pokrovskaja K; Jiang WQ; deThe H; Ringertz N; Klein G
Article: JOURNAL OF GENERAL VIROLOGY. 1995;76:2423-2432

REVERSIBLE NUCLEOLAR TRANSLOCATION OF EPSTEIN-BARR VIRUS-ENCODED EBNA-5 AND HSP70 PROTEINS AFTER EXPOSURE TO HEAT-SHOCK OR CELL-DENSITY CONGESTION

SZEKELY L; JIANG WQ; POKROVSKAJA K; WIMAN KG; KLEIN G; RINGERTZ N
Article: MOLECULAR CANCER RESEARCH. 1995;6(9):1071-1075

BCL-2 INHIBITS WILD-TYPE P53-TRIGGERED APOPTOSIS BUT NOT G(1) CELL-CYCLE ARREST AND TRANSACTIVATION OF WAF1 AND BAX

WANG YS; OKAN I; SZEKELY L; KLEIN G; WIMAN KG
Article: INTERNATIONAL JOURNAL OF CANCER. 1995;61(5):683-691

RB-RECONSTITUTED HUMAN RETINOBLASTOMA CELLS FORM RB-POSITIVE INTRAOCULAR AND INTRACEREBRAL BUT NOT SUBCUTANEOUS TUMORS IN SCID MICE

SZEKELY L; WANG YS; KLEIN G; WIMAN KG
Article: INTERNATIONAL IMMUNOLOGY. 1995;7(4):653-663

HLA-A0201 AND HLA-B7 BINDING PEPTIDES IN THE EBV-ENCODED EBNA-1, EBNA-2 AND BZLF-1 PROTEINS DETECTED IN THE MHC CLASS-I STABILIZATION ASSAY - LOW PROPORTION OF BINDING MOTIFS FOR SEVERAL HLA CLASS-I ALLELES IN EBNA-1

STUBER G; DILLNER J; MODROW S; WOLF H; SZEKELY L; KLEIN G; KLEIN E
Article: NUCLEIC ACIDS RESEARCH. 1995;23(3):362-369

P53 BINDS SINGLE-STRANDED-DNA ENDS THROUGH THE C-TERMINAL DOMAIN AND INTERNAL DNA SEGMENTS VIA THE MIDDLE DOMAIN

BAKALKIN G; SELIVANOVA G; YAKOVLEVA T; KISELEVA E; KASHUBA E; MAGNUSSON KP; SZEKELY L; KLEIN G; TERENIUS L; WIMAN KG
Journal article: INTERNATIONAL JOURNAL OF CANCER. 1994;58(5):663-667

MOLECULAR ANALYSIS OF THE RETINOBLASTOMA GENE IN PRIMARY OVARIAN-CANCER CELLS

LIU Y; HEYMAN M; WANG YS; FALKMER U; HISING C; SZEKELY L; EINHORN S
Journal article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1994;24(3):765-768

IDENTIFICATION OF WILD-TYPE AND MUTANT P53 PEPTIDES BINDING TO HLA-A2 ASSESSED BY A PEPTIDE LOADING-DEFICIENT CELL-LINE ASSAY AND A NOVEL MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PEPTIDE BINDING ASSAY

STUBER G; LEDER GH; STORKUS WJ; LOTZE MT; MODROW S; SZEKELY L; WOLF H; KLEIN E; KARRE K; KLEIN G
Journal article: ONCOGENE. 1994;9(3):809-818

CONTRASTING PATTERNS OF RETINOBLASTOMA PROTEIN EXPRESSION IN MOUSE EMBRYONIC STEM-CELLS AND EMBRYONIC FIBROBLASTS

SAVATIER P; HUANG S; SZEKELY L; WIMAN KG; SAMARUT J
Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1994;91(1):413-417

P53 BINDS SINGLE-STRANDED-DNA ENDS AND CATALYZES DNA RENATURATION AND STRAND TRANSFER

BAKALKIN G; YAKOVLEVA T; SELIVANOVA G; MAGNUSSON KP; SZEKELY L; KISELEVA E; KLEIN G; TERENIUS L; WIMAN KG
Journal article: ONCOGENE. 1993;8(12):3427-3431

WILD-TYPE P53-TRIGGERED APOPTOSIS IS INHIBITED BY BCL-2 IN A V-MYC-INDUCED T-CELL LYMPHOMA LINE

WANG YS; SZEKELY L; OKAN I; KLEIN G; WIMAN KG
Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1993;90(18):8697-8701

CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS WITH ALLELIC DELETIONS AT 13Q14 COMMONLY HAVE ONE INTACT RB1 GENE - EVIDENCE FOR A ROLE OF AN ADJACENT LOCUS

LIU Y; SZEKELY L; GRANDER D; SODERHALL S; JULIUSSON G; GAHRTON G; LINDER S; EINHORN S
Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1993;90(12):5455-5459

EBNA-5, AN EPSTEIN-BARR VIRUS-ENCODED NUCLEAR ANTIGEN, BINDS TO THE RETINOBLASTOMA AND P53 PROTEINS

SZEKELY L; SELIVANOVA G; MAGNUSSON KP; KLEIN G; WIMAN KG
Journal article: ONCOGENE. 1993;8(6):1495-1500

WILD-TYPE P53 INDUCED APOPTOSIS IN A BURKITT-LYMPHOMA (BL) LINE THAT CARRIES MUTANT P53

RAMQVIST T; MAGNUSSON KP; WANG YS; SZEKELY L; KLEIN G; WIMAN KG
Journal article: MOLECULAR CANCER RESEARCH. 1993;4(6):467-473

RECONSTITUTION OF WILD-TYPE P53 EXPRESSION TRIGGERS APOPTOSIS IN A P53-NEGATIVE V-MYC RETROVIRUS-INDUCED T-CELL LYMPHOMA LINE

WANG YS; RAMQVIST T; SZEKELY L; AXELSON H; KLEIN G; WIMAN KG
Journal article: JOURNAL OF CELLULAR PHYSIOLOGY. 1993;155(2):313-322

POSITION-DEPENDENT NUCLEAR ACCUMULATION OF THE RETINOBLASTOMA (RB) PROTEIN DURING INVITRO MYOGENESIS

SZEKELY L; JIN P; JIANG WQ; ROSEN A; WIMAN KG; KLEIN G; RINGERTZ N
Journal article: MOLECULAR CANCER RESEARCH. 1992;3(3):149-156

CELL TYPE AND DIFFERENTIATION DEPENDENT HETEROGENEITY IN RETINOBLASTOMA PROTEIN EXPRESSION IN SCID MOUSE FETUSES

SZEKELY L; JIANG WQ; BULICJAKUS F; ROSEN A; RINGERTZ N; KLEIN G; WIMAN KG
Journal article: BIOMEDICINE & PHARMACOTHERAPY. 1992;46(5-7):257

39. Involvement of the retinoblastoma (Rb) protein in the regulation of ceil differentiation

Szekely L; Jiang W; Savatier P; Bulic-Jakus F; Wendel-Hansen V; Rosen A; Ringertz N; Klein G; Wiman K
Journal article: BIOLOGY OF THE CELL. 1992;76(2):215

Absence of detectable RB protein in mouse embryonic stem (ES) cells contributes to E1A‐like activity

Huang S; Savatier P; Szekely L; Wiman KG; Samarut J
Journal article: EXPERIMENTAL CELL RESEARCH. 1991;197(2):314-318

COLOCALIZATION OF THE RETINOBLASTOMA PROTEIN AND THE EPSTEIN-BARR VIRUS-ENCODED NUCLEAR ANTIGEN EBNA-5

JIANG WQ; SZEKELY L; WENDELHANSEN V; RINGERTZ N; KLEIN G; ROSEN A
Journal article: GENES CHROMOSOMES & CANCER. 1991;3(5):403-406

INVOLVEMENT OF 3P DELETIONS IN SPORADIC AND HEREDITARY FORMS OF RENAL-CELL CARCINOMA

BOLDOG F; ARHEDEN K; IMREH S; STROMBECK B; SZEKELY L; ERLANDSSON R; MARCSEK Z; SUMEGI J; MITELMAN F; KLEIN G
Journal article: MOLECULAR CANCER RESEARCH. 1991;2(6):297-303

REINTRODUCTION OF A NORMAL RETINOBLASTOMA GENE INTO RETINOBLASTOMA AND OSTEOSARCOMA CELLS INHIBITS THE REPLICATION ASSOCIATED FUNCTION OF SV40 LARGE T-ANTIGEN

UZVOLGYI E; CLASSON M; HENRIKSSON M; HUANG HJS; SZEKELY L; LEE WH; KLEIN G; SUMEGI J
Journal article: MOLECULAR CANCER RESEARCH. 1991;2(6):287-295

SUBCELLULAR-LOCALIZATION OF THE RETINOBLASTOMA PROTEIN

SZEKELY L; UZVOLGYI E; JIANG WQ; DURKO M; WIMAN KG; KLEIN G; SUMEGI J
Journal article: EXPERIMENTAL CELL RESEARCH. 1991;193(2):420-424

INOSITOL DERIVATIVES DOWN-REGULATE C-MYC INDUCING GROWTH ARREST WITHOUT DIFFERENTIATION

SZABO G; SZEKELY L; SCHABLIK M; KLEIN G; SUMEGI J; SZABO G
Visa fler

Alla övriga publikationer

Letter: BLOOD CANCER JOURNAL. 2022;12(10):145

High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study

Li J; Han Q; Huang Y; Wei Y; Zi J; Zhao L; Cai Z; Lu X; Xiao R; Zhang Y; Yang X; Xu H; Sun N; Zhuang W; Wu Z; Xia Y; Xu Y; He B; Zhu W; Min F; Chen Y; Ding B; Shi P; Xie J; Tang H; Liu Z; Li B; Sun Y; Qiu H; Duan L; Dovat E; Song C; SzeKely L; Dovat S; Ge Z
Corrigendum: MALARIA JOURNAL. 2021;20(1):323

Direct contact between Plasmodium falciparum and human B-cells in a novel co-culture increases parasite growth and affects B-cell growth (vol 20, 303, 2021)

Reddy SB; Nagy N; Ronnberg C; Chiodi F; Lugaajju A; Heuts F; Szekely L; Wahlgren M; Persson KEM
Preprint: BIORXIV. 2021

Basal-to-classical phenotypic switch of pancreatic cancer cells upon integration into the duodenal epithelium

Bozóky B; Moro CF; Strell C; Ernberg I; Szekely L; Gerling M; Bozóky B
Preprint: BIORXIV. 2020

Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of Covid-19 death

Szekely L; Bozoky B; Bendek M; Ostad M; Lavignasse P; Haag L; Wu J; Jing X; Gupta S; Saccon E; Sönnerborg A; Cao Y; Björnstedt M; Szakos A
Preprint: BIORXIV. 2020

Tropism of SARS-CoV-2 in commonly used laboratory cell lines and their proteomic landscape during infection

Saccon E; Chen X; Mikaeloff F; Rodriguez JE; Szekely L; Vinhas BS; Krishnan S; Byrareddy SN; Frisan T; Végvári Á; Mirazimi A; Neogi U; Gupta S
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):308

Perforin deficiency within CD8⁺ T cells in sentinel lymph nodes of urothelial bladder cancer

Hartana CA; Rosenblatt R; Zirakzadeh AA; Bergman EA; Krantz D; Winerdal ME; Szekely L; Glise H; Sherif A; Winqvist O
Conference publication: HAEMATOLOGICA. 2014;99:326

IN VITRO COMPARATIVE STUDY ON DIRECT KILLING OF CLL CELLS BY SMALL TARGETED THERAPEUTIC MOLECULES

Sylvan SE; Skribek H; Norin S; Otvos R; Muhari O; Szekely L; Osterborg A
Conference publication: FREE RADICAL RESEARCH. 2009;43:63

Drug-specific responses to cytotoxic agents mediated by high levels of thioredoxin reductase 1 in human A549 cancer cells

Eriksson S; Prast-Nielsen S; Flaberg E; Szekely L; Arner E
Meeting abstract: BLOOD REVIEWS. 2007;21:S98-S99

Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells

Markasz L; Stuber G; Flaberg E; Jernberg AG; Eksborg S; Olah E; Skribek H; Szekely L
Published conference paper: IMMUNOLOGY LETTERS. 2002;82(1-2):141-147

The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells

Nagy N; Mattsson K; Maeda A; Liu AQ; Székely L; Klein E
Book chapter: ONCOGENES AND TUMOUR SUPPRESSORS. 1997;p. 3-32

Mechanisms of oncogene perturbation

Imreh S; Szekely L; Wiman KG; Klein G
Published conference paper: EXPERIMENTAL CELL RESEARCH. 1996;229(2):289-300

Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line

Jiang WQ; Szekely L; Klein G; Ringertz N
Other: ONCOGENE. 1995;10(9):1869-1874

RESTING B-CELLS, EBV-INFECTED B-BLASTS AND ESTABLISHED LYMPHOBLASTOID CELL-LINES DIFFER IN THEIR RB, P53 AND EBNA-5 EXPRESSION PATTERNS

SZEKELY L; POKROVSKAJA K; JIANG WQ; SELIVANOVA G; LOWBEER M; RINGERTZ N; WIMAN KG; KLEIN G
Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1995;:325

P53 BINDS SINGLE-STRANDED-DNA ENDS THROUGH C-TERMINAL DOMAIN AND INTERNAL DNA SEGMENTS VIA THE MIDDLE DOMAIN

SELIVANOVA G; BAKALKIN G; YAKOVLEVA T; KISELEVA E; SZEKELY L; TERENIUS L; WIMAN KG
Conference publication: BLOOD. 1995;86(10):645

Physical interaction between the retinoblastoma (RB) and promyelocytic leukemia (PML) gene products

Alcalay M; Tomassoni L; Fagioli M; Grignani F; Helin K; Szekely L; Pelicci PG
Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1995;:77

P53 BINDS SINGLE-STRANDED-DNA ENDS THROUGH C-TERMINAL DOMAIN AND INTERNAL DNA SEGMENTS VIA THE MIDDLE DOMAIN

SELIVANOVA G; BAKALKIN G; YAKOVLEVA T; KISELEVA E; SZEKELY L; TERENIUS L; WIMAN KG
Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1994;:181

CONTRASTING PATTERNS OF RETINOBLASTOMA PROTEIN EXPRESSION IN MOUSE EMBRYONIC STEM-CELLS AND EMBRYONIC FIBROBLASTS

SAVATIER P; SZEKELY L; WIMAN KG; SAMARUT J
Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1994;:181

P53 BINDS SINGLE-STRANDED-DNA ENDS AND CATALYZES DNA RENATURATION AND STRAND TRANSFER

SELIVANOVA G; BAKALKIN G; YAKOVLEVA T; MAGNUSSON KP; SZEKELY L; KISELEVA E; KLEIN G; TERENIUS L; WIMAN KG

Forskningsbidrag

Therapeutically targetable pathophysiological changes in the bodies of Covid-19 victims and post-Covid patients identified by BSL3 autopsies

Swedish Research Council

1 December 2021 - 30 November 2025
Therapeutically targetable pathophysiological changes in the lungs and hearts of Covid-19 victims and post-Covid patients identified by BSL3 autopsies

Swedish Heart-Lung Foundation

1 January 2021 - 31 December 2021
Identification of mechanisms that control the growth of tumor cells in tissue and the development of methods that enable large-scale search of drugs targeting such control functions

Swedish Cancer Society

1 January 2015
Clinical biomarkers for ROS-based anticancer therapy

Swedish Foundation for Strategic Research

1 January 2015 - 31 December 2019
Identification of mechanisms that control the growth of tumor cells in tissue and the development of methods that enable large-scale search of drugs targeting such control functions

Swedish Cancer Society

1 January 2014
Do normal fibroblasts from patients with high and low cancer propensity differ in their ability to inhibit the growth of cancer cells?

Swedish Research Council

1 January 2013 - 31 December 2015
Determination of the drug sensitivity pattern of primary human tumor cells using automated microscopy to aid assay guided individualized therapy of cancer patients

Swedish Research Council

1 January 2011 - 31 December 2013
Do normal fibroblasts from patients with high and low cancer propensity differ in their ability to inhibit the growth of cancer cells?

Swedish Research Council

1 January 2010 - 31 December 2012

Anställningar

Anknuten till Undervisning/Handledning, Laboratoriemedicin, Karolinska Institutet, 2023-2025
Professor, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2010-2014
Universitetslektor, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2010-2010
Rådsforskare, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2007-2009
Forskare, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 1996-2007
Doktorand, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 1995-1995

Examina och utbildning

Docent, Inriktning: tumörbiologi, Karolinska Institutet, 2000
Läkarexamen, medicine, Production of monoclonal antibodies against vimentin (in Hungarian), Medicinsk Biologi, DOTE, 1988

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI